Background: Only sparse evidence from controlled clinical trials is available to guide the psychiatric treatment of persons with HIV/AIDS. Objective: The authors assessed and determined current treatment trends in AIDS psychiatry. Method: Members of the Organization of AIDS Psychiatry (OAP) participated in a web-based survey. Results: Of 159 members, 62 (39%) responded to the survey. Consensus emerged regarding first-line treatment for depression (escitalopram/ citalopram), for psychosis and secondary mania (quetiapine), and for anxiety (clonazepam). Conclusion: Consensus statements can serve as a preliminary step toward providing some standardization of care for persons with HIV/AIDS.
ASJC Scopus subject areas
- Arts and Humanities (miscellaneous)
- Applied Psychology
- Psychiatry and Mental health